(Q40463624)

20 September 2017

1 reference

title

Fluconazole. An update of its antimicrobial activity, pharmacokinetic properties, and therapeutic use in vaginal candidiasis. (English)

1 reference

20 September 2017

1 reference

1 reference

C M Perry

1

1 reference

20 September 2017

R Whittington

series ordinal

2

1 reference

20 September 2017

D McTavish

series ordinal

3

1 reference

20 September 2017

publication date

1 June 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

49

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

984-1006

1 reference

Anaphylactic reaction after oral fluconazole

20 September 2017

cites work

1 reference

12 December 2020

Standardized susceptibility testing of fluconazole: an international collaborative study

1 reference

12 December 2020

Phenytoin toxicity induced by fluconazole

1 reference

12 December 2020

The rectal carriage of yeast in patients with vaginal candidiasis

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

Effect of fluconazole on the interactions between human neutrophils and Candida albicans

1 reference

12 December 2020

Oral azole drugs as systemic antifungal therapy

1 reference

12 December 2020

Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.

1 reference

12 December 2020

A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial

1 reference

12 December 2020

Adverse drug reactions to systemic antifungals. Prevention and management

1 reference

12 December 2020

Effect of fluconazole on the disposition of phenytoin

1 reference

12 December 2020

Is there a role for fluconazole in the treatment of vulvovaginal candidiasis?

1 reference

12 December 2020

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata

1 reference

12 December 2020

Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of fluconazole in humans

1 reference

12 December 2020

Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis

1 reference

12 December 2020

Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study

1 reference

12 December 2020

Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates.

1 reference

12 December 2020

Effect of oral antacid administration on the pharmacokinetics of oral fluconazole

1 reference

12 December 2020

Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy

1 reference

12 December 2020

Clinical pharmacology of fluconazole

1 reference

12 December 2020

Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading

1 reference

12 December 2020

Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture

1 reference

12 December 2020

In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B

1 reference

12 December 2020

Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole

1 reference

12 December 2020

Possible potentiation of warfarin by fluconazole

1 reference

12 December 2020

Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis

1 reference

12 December 2020

Shorter treatment for vaginal candidosis: comparison between single-dose oral fluconazole and three-day treatment with local miconazole

1 reference

12 December 2020

Fluconazole-resistant Candida albicans

1 reference

12 December 2020

Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.

1 reference

12 December 2020

Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp

1 reference

12 December 2020

Clinical pharmacokinetics of fluconazole

1 reference

12 December 2020

An assessment of the effects of impaired renal function and haemodialysis on the pharmacokinetics of fluconazole

1 reference

12 December 2020

Correlation between in vitro and in vivo activity of antifungal agents against Candida species

1 reference

12 December 2020

Fluconazole-induced jaundice

1 reference

12 December 2020

Treatment of candidal vaginitis A prospective randomized investigator-blind multicenter study comparing topically applied econazole with oral fluconazole

1 reference

12 December 2020

Fluconazole (Diflucan): a review

1 reference

12 December 2020

Possible interaction between warfarin and fluconazole

1 reference

12 December 2020

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

1 reference

12 December 2020

Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy

1 reference

12 December 2020

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

12 December 2020

Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles.

1 reference

12 December 2020

A randomized, comparative study of a single oral dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists

1 reference

12 December 2020

Discovery of fluconazole, a novel antifungal agent

1 reference

12 December 2020

Drug interactions with fluconazole

1 reference

12 December 2020

In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole

1 reference

12 December 2020

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

1 reference

12 December 2020

An open multicentre study of the efficacy and safety of a single dose of fluconazole 150 mg in the treatment of vaginal candidiasis in general practice

1 reference

12 December 2020

The discovery and profile of fluconazole

1 reference

12 December 2020

Pharmacokinetics of fluconazole in normal volunteers

1 reference

12 December 2020

Fluconazole-cyclosporine interaction: a dose-dependent effect?

1 reference

12 December 2020

Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties

1 reference

12 December 2020

Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group

1 reference

12 December 2020

Azole antifungal agents: emphasis on new triazoles

1 reference

12 December 2020

Angio-oedema after fluconazole

1 reference

12 December 2020

Azole Antifungal Agents

1 reference

12 December 2020

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

1 reference

12 December 2020

Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects

1 reference

12 December 2020

Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis

1 reference

12 December 2020

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

1 reference

12 December 2020

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

1 reference

12 December 2020

Antifungal therapy and the new azole compounds

1 reference

12 December 2020

Fluconazole-associated acute adrenal insufficiency

1 reference

12 December 2020

In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole and amphotericin B

1 reference

12 December 2020

Stevens-Johnson syndrome after fluconazole

1 reference

12 December 2020

[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis]

1 reference

12 December 2020

Comparison of fluconazole and ketoconazole in the therapy of vaginal candidiasis by administration in two different oral doses

1 reference

12 December 2020

Treatment of vaginal candidosis with fluconazole

1 reference

12 December 2020

Vulvovaginal candidiasis refractory to treatment with fluconazole

1 reference

12 December 2020

A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial

1 reference

12 December 2020

Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole

1 reference

12 December 2020

Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions

1 reference

12 December 2020

In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole

1 reference

12 December 2020

Effect of fluconazole on zidovudine pharmacokinetics in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Induction of fluconazole metabolism by rifampin: in vivo study in humans.

1 reference

12 December 2020

Fluconazole resistance in Candida glabrata

1 reference

12 December 2020

In vitro effects of fluconazole (UK-49,858) and ketoconazole on mouse lymphocyte proliferation and on Candida blastospore destruction by human polymorphonuclear leukocytes

1 reference

12 December 2020

Fluconazole-induced symptomatic phenytoin toxicity

1 reference

12 December 2020

Single-dose oral fluconazole versus single-dose topical miconazole for the treatment of acute vulvovaginal candidosis

1 reference

12 December 2020

Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies

1 reference

12 December 2020

Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group

1 reference

12 December 2020

10.2165/00003495-199549060-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1024969583

0 references

1 reference